HighSTEACS
Start date:June 2014 End date:
March 2017 Co-ordinated by:
University of Edinburgh & NHS Lothian
HighSTEACS is a randomised controlled trial, across 10 hospitals in NHS Lothian and NHS Greater Glasgow & Clyde, assessing patient outcomes before and after the implementation of high sensitivity Troponin assay
Research Team
EMERGE Research team
Cardiology Research Group
Aim
HighSTEACS is a randomised controlled trial, across 10 hospitals in NHS Lothian and NHS Greater Glasgow & Clyde, assessing patient outcomes before and after the implementation of high sensitivity Troponin assay. The primary endpoint is the one-year rate of cardiovascular death or recurrent myocardial infarction. Secondary endpoints include length of stay, unplanned coronary revascularisation, recurrent hospital admissions excluding ACS, bleeding events and non-cardiovascular death. There is also a sub-study at the ED, RIE and in one site in NHS Greater Glasgow and Clyde.
Trial Design
Prospective stepped wedge cluster randomised controlled trial
Eligibility criteria (summary)
Patients who present to the Emergency Department with suspected heart disease
Chief Investigator
Professor Nick Mills
Chair of Cardiology
Local PI
Professor Alasdair Gray
Honorary Professor of Emergency Medicine & Clinical Director of the Emergency Department
Research Team
Rachel O'Brien
Lead Research Nurse
Hedda Nyhus
Senior Research Nurse
Bev Goldberg
AMU Senior Research Nurse
Megan McGrath
Senior Research Nurse
More EMERGE Trials
ATTEST2 Trial
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)
Assisting in identifying patients with Humeral shaft fractures in the ED by screening.
Giving patient information sheets to introduce the study, so patient has had adequate time to read and make decision about going into the trial before going to the fracture clinic.
HU-FIX Trial
DASH Trial
DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.